COMBINATION OF RAMUCIRUMAB AND PEMBROLIZUMAB FOR THE TREATMENT OF CERTAIN CANCERS

摘要

The present disclosure relates to a combination of ramucirumab and pembrolizumab and methods of using the combination to treat certain disorders, such as non-small cell lung cancer, urothelial cancer, biliary tract cancer, and advanced gastric or gastroesophageal junction adenocarcinoma.